Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients

被引:21
|
作者
Vignoli, M
Stecca, B
Furlini, G
Re, MC
Mantovani, V
Zauli, G
Visani, G
Colangeli, V
La Placa, M
机构
[1] Univ Bologna, Dept Clin & Expt Med, Microbiol Sect, Bologna, Italy
[2] St Orsola Gen Hosp, Cent Lab, Bologna, Italy
[3] Univ Ferrara, Inst Human Anat, I-44100 Ferrara, Italy
[4] Univ Bologna, Inst Haematol, Bologna, Italy
[5] Univ Bologna, Infect Dis Sect, Bologna, Italy
关键词
telomerase; haematopoietic progenitor cells; HIV-1; infection; transforming growth factor-beta 1; gp120;
D O I
10.1097/00002030-199809000-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Haematopoietic progenitor cells (HPC) of HIV-l-infected patients are severely compromised in their replication and clonogenic capacities, and show an enhanced propensity to apoptosis, despite the lack of productive or latent HIV-1 infection. Objective: To investigate telomerase enzyme levels in CD34+ HPC isolated from HIV-1-infected patients, because the absence of telomerase activity has been found to be correlated with a diminished replication potential. Methods: Telomerase levels were measured by a PCR-based telomeric repeat amplification protocol. CD34+ HPC isolated from the peripheral blood of 11 HIV-1-infected patients were compared with CD34+ HPC isolated from peripheral blood (nine subjects) or bone marrow (six subjects) from 15 healthy donors. Telomerase levels were also studied in normal HPC after exposure to either gp120 or transforming growth factor (TGF)-beta 1. Results: CD34+ HPC isolated from either peripheral blood or bone marrow from healthy donors expressed a high level of telomerase activity. On the contrary, CD34+ HPC isolated from HIV-1-seropositive patients did not express any detectable telomerase activity in nine patients, and a clearly reduced enzymatic activity in two patients. Furthermore, telomerase activity in normal CD34+ HPC exposed to recombinant gp120 was significantly reduced, and to a higher extent than in CD34+ HPC exposed to recombinant TCF-beta 1. Conclusions: This is the first study to demonstrate severely impaired telomerase activity in uninfected CD34+ HPC isolated from HIV-1-infected patients. The mechanism underlying this impairment probably involves the interaction of HIV-1 envelope glycoprotein gp120 with the cell membrane. These results may add to our understanding of the pathogenesis of the lesion of the HPC compartment. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:999 / 1005
页数:7
相关论文
共 50 条
  • [21] REACTIVITIES OF HIV-1 GAG-DERIVED PEPTIDES WITH ANTIBODIES OF HIV-1-INFECTED AND UNINFECTED HUMANS
    HAIST, S
    MARZ, J
    WOLF, H
    MODROW, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (11) : 1909 - 1917
  • [22] Chlamydia pneumoniae seroprevalence among HIV-1-infected and uninfected people with known HIV risk factor
    Comandini, UV
    Massetti, AP
    Marchese, R
    Zaccarelli, M
    Vullo, V
    Delia, S
    AIDS, 1996, 10 (13) : 1543 - 1547
  • [23] Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review
    Gianotti, Nicola
    Soria, Alessandro
    Lazzarin, Adriano
    NEW MICROBIOLOGICA, 2007, 30 (02): : 79 - 88
  • [24] IMPAIRED INVITRO PROLIFERATION OF HEMATOPOIETIC PRECURSORS IN HIV-1-INFECTED SUBJECTS
    LUNARDIISKANDAR, Y
    GEORGOULIAS, V
    BERTOLI, AM
    AUGERYBOURGET, Y
    AMMAR, A
    VITTECOQ, D
    ROSENBAUM, W
    MEYER, P
    JASMIN, C
    LEUKEMIA RESEARCH, 1989, 13 (07) : 573 - 581
  • [25] MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES
    LIUZZI, GM
    MASTROIANNI, CM
    FANELLI, M
    MASSETTI, AP
    VULLO, V
    DELIA, S
    RICCIO, P
    NEUROREPORT, 1994, 6 (01) : 157 - 160
  • [26] HIV-2-INFECTED PATIENTS SURVIVE LONGER THAN HIV-1-INFECTED PATIENTS
    WHITTLE, H
    MORRIS, J
    TODD, J
    CORRAH, T
    SABALLY, S
    BANGALI, J
    NGOM, PT
    ROLFE, M
    WILKINS, A
    AIDS, 1994, 8 (11) : 1617 - 1620
  • [27] A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women
    Spear, GT
    AlHarthi, L
    Sha, B
    Saarloos, MN
    Hayden, M
    Massad, LS
    Benson, C
    Roebuck, KA
    Glick, NR
    Landay, A
    AIDS, 1997, 11 (11) : 1319 - 1326
  • [28] Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women
    Aldrovandi, Grace M.
    Chu, Clara
    Shearer, William T.
    Li, Daner
    Walter, Jan
    Thompson, Bruce
    McIntosh, Kenneth
    Foca, Marc
    Meyer, William A., III
    Ha, Belinda F.
    Rich, Kenneth C.
    Moye, Jack, Jr.
    PEDIATRICS, 2009, 124 (06) : E1189 - E1197
  • [29] Effectiveness of ezetimibe on hyperlipidaemia in HIV-1-infected patients
    von Lintig, FC
    Lee, D
    Patel, P
    Epp, J
    Barber, R
    Mathews, WC
    ANTIVIRAL THERAPY, 2004, 9 (06) : L48 - L49
  • [30] Indinavir in cerebrospinal fluid of HIV-1-infected patients
    Ståhle, L
    Martin, C
    Svensson, JO
    Sönnerborg, A
    LANCET, 1997, 350 (9094): : 1823 - 1823